Skip to main content

María Delgado Muñoz

Institutions of which they are part

Research technician
Pediatric Neurology
Vall Hebron Institut de Recerca

María Delgado Muñoz

Institutions of which they are part

Research technician
Pediatric Neurology
Vall Hebron Institut de Recerca

Related news

The donation will enable further characterisation of patients with this rare disease, the identification of new biomarkers and the exploration of innovative therapies.

The clinical trial, which also involved Vall d’Hebron, shows that the new therapy improves survival by 86% in patients with thymidine kinase 2 deficiency (TK2d).

The ClinPrior algorithm achieved a positive diagnosis rate of 70% in two minority diseases of neurodegenerative origin, which represents double the number of cases that are diagnosed with current tools.

Related professionals

Maria Luz Uría Oficialdegui

Maria Luz Uría Oficialdegui

Predoctoral researcher
Childhood Cancer and Blood Disorders
Read more
Oscar José Hernández Cristancho

Oscar José Hernández Cristancho

Predoctoral researcher
Physiology and Pathophysiology of the Digestive Tract
Read more
Eva Llarch Pinell

Eva Llarch Pinell

Main researcher
Research on Aging, Frailty and Transitions in Barcelona
Read more
Melissa Panesso Romero

Melissa Panesso Romero

Predoctoral researcher
Childhood Cancer and Blood Disorders
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.